ScholarIQanswers from OpenAlex
Kagoshima University
InstitutionResearch output, impact & collaborations
Kagoshima University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Kagoshima University?
ScholarIQrecord summary
Kagoshima University is a research organisation in Kagoshima, JP. OpenAlex records 43,723 works and 2,338,522 citations for it. 9,609 researchers list it as their most recent affiliation.
How many works does Kagoshima University have?
ScholarIQindexed works
Kagoshima University has 43,723 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kagoshima University have?
ScholarIQcitation count
Kagoshima University has 2,338,522 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Kagoshima University?
ScholarIQresearcher count
Kagoshima University has 9,609 researchers in the ScholarIQ index.
What is the average h-index at Kagoshima University?
ScholarIQavg h-index
Kagoshima University has an average h-index of 57.1 in OpenAlex.
What is the ROR of Kagoshima University?
ScholarIQror
The ROR for Kagoshima University is on the source record.
What is the OpenAlex record for Kagoshima University?
ScholarIQopenalex
The OpenAlex for Kagoshima University is on the source record.
Who are the most-cited researchers behind Kagoshima University?
ScholarIQtop researchers by citations
What are the most-cited papers on Kagoshima University?
ScholarIQmost cited works
Sarcopenia With Limited Mobility: An International Consensus
John E. Morley, Angela Marie Abbatecola, Josep M. Argilés, Vickie E. Baracos, Juergen Bauer, Shalender Bhasin, Tommy Cederholm, Andrew J.S. Coats, Steven R. Cummings, William J. Evans, Kenneth C.H. Fearon, Luigi Ferrucci, Roger A. Fielding, Jack M. Guralnik, Tamara B. Harris, Akio Inui, Kamyar Kalantar‐Zadeh, Bridget‐Anne Kirwan, Giovanni Mantovani, Maurizio Muscaritoli, Anne B. Newman, Filippo Rossi Fanelli, Giuseppe Rosano, Ronenn Roubenoff, Morris Schambelan, Gerald H. Sokol, Thomas W. Storer, Bruno Vellas, Stephan von Haehling, Shing-Shing Yeh, Stefan D. Anker
Ghrelin
Timo D. Müller, Rubén Nogueiras, Mark L. Andermann, Zane B. Andrews, Stefan D. Anker, Jesús Argente, Rachel L. Batterham, S.C. Benoit, C. Y. Bowers, Fabio Broglio, Felipe F. Casanueva, David A. D’Alessio, Inge Depoortere, Allan Geliebter, Ezio Ghigo, Philip A. Cole, Michael A. Cowley, D. E. Cummings, Alain Dagher, Sabrina Diano, Suzanne L. Dickson, Carlos Diéguez, Riccarda Granata, Harvey J. Grill, Kelly Grove, Kirk M. Habegger, Kristy M. Heppner, Mark L. Heiman, Laura M. Holsen, Birgitte Holst, Akio Inui, J-O Jansson, Henriette Kirchner, Márta Korbonits, Blandine Laferrère, C.W. LeRoux, Miguel López, Sophie Morin, Michiko Nakazato, Ralf Nass, Diego Pérez–Tilve, Paul T. Pfluger, Thue W. Schwartz, Randy J. Seeley, Mark W. Sleeman, Yuxiang Sun, Lori Sussel, Jenny Tong, Michael O. Thorner, A. J. van der Lely, L. H. T. Van der Ploeg, Jeffrey M. Zigman, Masayasu Kojima, Kenji Kangawa, R G Smith, Tamás L. Horváth, M. Tschöp
Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial
Hiroaki Saito, Ikuro Maruyama, S Shimazaki, Yasuhiro Yamamoto, Naoki Aikawa, R Ohno, Akio Hirayama, T Matsuda, Hidesaku Asakura, Megan O. Nakashima, N Aoki
The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor Biosynthesis
Toshio Miyata, Junji Takeda, Yoshiyasu Iida, Norio Yamada, Norimitsu Inoue, Minoru Takahashi, Kenji Maeda, Teruo Kitani, Taroh Kinoshita
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
Toshio Miyata, Osamu Oda, Reiko Inagi, Yuichiro Iida, Norie Araki, Norio Yamada, Seikoh Horiuchi, Naoyuki Taniguchi, Kenji Maeda, Taroh Kinoshita
How much of the research on Kagoshima University is open access?
ScholarIQopen access share
50%OPEN ACCESS